Medical - Healthcare Information Services
Compare Stocks
4 / 10Stock Comparison
HCTI vs MTEX vs HIMS vs AMZN
Revenue, margins, valuation, and 5-year total return — side by side.
Household & Personal Products
Medical - Equipment & Services
Specialty Retail
HCTI vs MTEX vs HIMS vs AMZN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Medical - Healthcare Information Services | Household & Personal Products | Medical - Equipment & Services | Specialty Retail |
| Market Cap | $49K | $9M | $6.63B | $2.92T |
| Revenue (TTM) | $13M | $110M | $2.35B | $742.78B |
| Net Income (TTM) | $-6M | $-2M | $128M | $90.80B |
| Gross Margin | 13.1% | 75.1% | 69.7% | 50.6% |
| Operating Margin | -45.2% | 0.5% | 4.6% | 11.5% |
| Forward P/E | — | 3.5x | 51.5x | 34.8x |
| Total Debt | $3M | $7M | $1.12B | $152.99B |
| Cash & Equiv. | $20K | $11M | $229M | $86.81B |
HCTI vs MTEX vs HIMS vs AMZN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Oct 21 | May 26 | Return |
|---|---|---|---|
| Healthcare Triangle… (HCTI) | 100 | 0.0 | -100.0% |
| Mannatech, Incorpor… (MTEX) | 100 | 11.5 | -88.5% |
| Hims & Hers Health,… (HIMS) | 100 | 329.0 | +229.0% |
| Amazon.com, Inc. (AMZN) | 100 | 160.8 | +60.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HCTI vs MTEX vs HIMS vs AMZN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HCTI lags the leaders in this set but could rank higher in a more targeted comparison.
MTEX is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 0 yrs, beta 0.27
- Lower volatility, beta 0.27, Low D/E 77.7%, current ratio 1.25x
- Beta 0.27, current ratio 1.25x
- Lower P/E (3.5x vs 34.8x)
HIMS is the clearest fit if your priority is growth exposure.
- Rev growth 59.0%, EPS growth -3.8%, 3Y rev CAGR 64.5%
- 59.0% revenue growth vs HCTI's -64.8%
AMZN carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 7.0% 10Y total return vs HIMS's 161.9%
- 12.2% margin vs HCTI's -48.9%
- +43.7% vs HCTI's -99.9%
- 11.5% ROA vs HCTI's -60.0%, ROIC 14.7% vs -6.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 59.0% revenue growth vs HCTI's -64.8% | |
| Value | Lower P/E (3.5x vs 34.8x) | |
| Quality / Margins | 12.2% margin vs HCTI's -48.9% | |
| Stability / Safety | Beta 0.27 vs HCTI's 3.07 | |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | +43.7% vs HCTI's -99.9% | |
| Efficiency (ROA) | 11.5% ROA vs HCTI's -60.0%, ROIC 14.7% vs -6.3% |
HCTI vs MTEX vs HIMS vs AMZN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
HCTI vs MTEX vs HIMS vs AMZN — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AMZN leads in 2 of 6 categories
MTEX leads 1 • HCTI leads 0 • HIMS leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — MTEX and AMZN each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AMZN is the larger business by revenue, generating $742.8B annually — 57397.1x HCTI's $13M. AMZN is the more profitable business, keeping 12.2% of every revenue dollar as net income compared to HCTI's -48.9%. On growth, HCTI holds the edge at +44.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $13M | $110M | $2.3B | $742.8B |
| EBITDAEarnings before interest/tax | -$6M | $2M | $164M | $155.9B |
| Net IncomeAfter-tax profit | -$6M | -$2M | $128M | $90.8B |
| Free Cash FlowCash after capex | -$12M | -$4M | $73M | -$2.5B |
| Gross MarginGross profit ÷ Revenue | +13.1% | +75.1% | +69.7% | +50.6% |
| Operating MarginEBIT ÷ Revenue | -45.2% | +0.5% | +4.6% | +11.5% |
| Net MarginNet income ÷ Revenue | -48.9% | -1.5% | +5.5% | +12.2% |
| FCF MarginFCF ÷ Revenue | -94.7% | -3.6% | +3.1% | -0.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +44.6% | -8.1% | +28.4% | +16.6% |
| EPS Growth (YoY)Latest quarter vs prior year | -63.8% | +6.9% | -27.3% | +74.8% |
Valuation Metrics
MTEX leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 3.5x trailing earnings, MTEX trades at a 93% valuation discount to HIMS's 50.3x P/E. On an enterprise value basis, MTEX's 1.4x EV/EBITDA is more attractive than HIMS's 42.7x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $49,177 | $9M | $6.6B | $2.92T |
| Enterprise ValueMkt cap + debt − cash | $3M | $4M | $7.5B | $2.98T |
| Trailing P/EPrice ÷ TTM EPS | -0.01x | 3.54x | 50.32x | 37.82x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 51.51x | 34.77x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 1.35x |
| EV / EBITDAEnterprise value multiple | — | 1.41x | 42.68x | 20.47x |
| Price / SalesMarket cap ÷ Revenue | 0.00x | 0.08x | 2.82x | 4.07x |
| Price / BookPrice ÷ Book value/share | — | 1.02x | 12.25x | 7.14x |
| Price / FCFMarket cap ÷ FCF | — | 4.52x | 89.61x | 378.98x |
Profitability & Efficiency
AMZN leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
HIMS delivers a 23.7% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $-113 for HCTI. AMZN carries lower financial leverage with a 0.37x debt-to-equity ratio, signaling a more conservative balance sheet compared to HIMS's 2.07x. On the Piotroski fundamental quality scale (0–9), AMZN scores 6/9 vs HCTI's 3/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -112.9% | -23.8% | +23.7% | +23.3% |
| ROA (TTM)Return on assets | -60.0% | -4.9% | +6.0% | +11.5% |
| ROICReturn on invested capital | -6.3% | +17.3% | +10.7% | +14.7% |
| ROCEReturn on capital employed | — | +9.3% | +10.9% | +15.3% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 5 | 4 | 6 |
| Debt / EquityFinancial leverage | — | 0.78x | 2.07x | 0.37x |
| Net DebtTotal debt minus cash | $3M | -$5M | $892M | $66.2B |
| Cash & Equiv.Liquid assets | $20,000 | $11M | $229M | $86.8B |
| Total DebtShort + long-term debt | $3M | $7M | $1.1B | $153.0B |
| Interest CoverageEBIT ÷ Interest expense | -3.79x | 0.38x | — | 39.96x |
Total Returns (Dividends Reinvested)
AMZN leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HIMS five years ago would be worth $23,764 today (with dividends reinvested), compared to $0 for HCTI. Over the past 12 months, AMZN leads with a +43.7% total return vs HCTI's -99.9%. The 3-year compound annual growth rate (CAGR) favors AMZN at 36.8% vs HCTI's -96.0% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -93.7% | -44.1% | -23.2% | +19.7% |
| 1-Year ReturnPast 12 months | -99.9% | -53.3% | -51.0% | +43.7% |
| 3-Year ReturnCumulative with dividends | -100.0% | -63.8% | +116.6% | +156.2% |
| 5-Year ReturnCumulative with dividends | -100.0% | -61.0% | +137.6% | +64.8% |
| 10-Year ReturnCumulative with dividends | -100.0% | -35.2% | +161.9% | +697.8% |
| CAGR (3Y)Annualised 3-year return | -96.0% | -28.8% | +29.4% | +36.8% |
Risk & Volatility
Evenly matched — MTEX and AMZN each lead in 1 of 2 comparable metrics.
Risk & Volatility
MTEX is the less volatile stock with a 0.27 beta — it tends to amplify market swings less than HCTI's 3.07 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMZN currently trades 97.3% from its 52-week high vs HCTI's 0.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.07x | 0.27x | 2.40x | 1.51x |
| 52-Week HighHighest price in past year | $7410.00 | $12.45 | $70.43 | $278.56 |
| 52-Week LowLowest price in past year | $0.29 | $4.20 | $13.74 | $185.01 |
| % of 52W HighCurrent price vs 52-week peak | +0.0% | +37.5% | +36.4% | +97.3% |
| RSI (14)Momentum oscillator 0–100 | 36.7 | 43.6 | 54.5 | 81.1 |
| Avg Volume (50D)Average daily shares traded | 572K | 10K | 34.9M | 45.5M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: HIMS as "Hold", AMZN as "Buy". Consensus price targets imply 15.6% upside for HIMS (target: $30) vs 13.1% for AMZN (target: $307).
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Hold | Buy |
| Price TargetConsensus 12-month target | — | — | $29.67 | $306.77 |
| # AnalystsCovering analysts | — | — | 19 | 94 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | 0 | — | — |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +1.4% | 0.0% |
AMZN leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). MTEX leads in 1 (Valuation Metrics). 2 tied.
HCTI vs MTEX vs HIMS vs AMZN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is HCTI or MTEX or HIMS or AMZN a better buy right now?
For growth investors, Hims & Hers Health, Inc.
(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus -64. 8% for Healthcare Triangle, Inc. (HCTI). Mannatech, Incorporated (MTEX) offers the better valuation at 3. 5x trailing P/E, making it the more compelling value choice. Analysts rate Amazon. com, Inc. (AMZN) a "Buy" — based on 94 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HCTI or MTEX or HIMS or AMZN?
On trailing P/E, Mannatech, Incorporated (MTEX) is the cheapest at 3.
5x versus Hims & Hers Health, Inc. at 50. 3x. On forward P/E, Amazon. com, Inc. is actually cheaper at 34. 8x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — HCTI or MTEX or HIMS or AMZN?
Over the past 5 years, Hims & Hers Health, Inc.
(HIMS) delivered a total return of +137. 6%, compared to -100. 0% for Healthcare Triangle, Inc. (HCTI). Over 10 years, the gap is even starker: AMZN returned +697. 8% versus HCTI's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HCTI or MTEX or HIMS or AMZN?
By beta (market sensitivity over 5 years), Mannatech, Incorporated (MTEX) is the lower-risk stock at 0.
27β versus Healthcare Triangle, Inc. 's 3. 07β — meaning HCTI is approximately 1047% more volatile than MTEX relative to the S&P 500. On balance sheet safety, Amazon. com, Inc. (AMZN) carries a lower debt/equity ratio of 37% versus 2% for Hims & Hers Health, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — HCTI or MTEX or HIMS or AMZN?
By revenue growth (latest reported year), Hims & Hers Health, Inc.
(HIMS) is pulling ahead at 59. 0% versus -64. 8% for Healthcare Triangle, Inc. (HCTI). On earnings-per-share growth, the picture is similar: Mannatech, Incorporated grew EPS 210. 0% year-over-year, compared to -3. 8% for Hims & Hers Health, Inc.. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HCTI or MTEX or HIMS or AMZN?
Amazon.
com, Inc. (AMZN) is the more profitable company, earning 10. 8% net margin versus -51. 0% for Healthcare Triangle, Inc. — meaning it keeps 10. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMZN leads at 11. 2% versus -40. 6% for HCTI. At the gross margin level — before operating expenses — MTEX leads at 77. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HCTI or MTEX or HIMS or AMZN more undervalued right now?
On forward earnings alone, Amazon.
com, Inc. (AMZN) trades at 34. 8x forward P/E versus 51. 5x for Hims & Hers Health, Inc. — 16. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HIMS: 15. 6% to $29. 67.
08Which pays a better dividend — HCTI or MTEX or HIMS or AMZN?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is HCTI or MTEX or HIMS or AMZN better for a retirement portfolio?
For long-horizon retirement investors, Mannatech, Incorporated (MTEX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
27)). Healthcare Triangle, Inc. (HCTI) carries a higher beta of 3. 07 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MTEX: -35. 2%, HCTI: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HCTI and MTEX and HIMS and AMZN?
These companies operate in different sectors (HCTI (Healthcare) and MTEX (Consumer Defensive) and HIMS (Healthcare) and AMZN (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: HCTI is a small-cap quality compounder stock; MTEX is a small-cap deep-value stock; HIMS is a small-cap high-growth stock; AMZN is a mega-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.